Clinical Trials Sponsored by BioDlogics

Total 615 results

Osteotech, Inc

Completed

Study Performance of The Plexur P™ Bone Void Filler Device in Patients Undergoing Iliac Crest Harvesting Procedures

Iliac Crest Harvesting Procedure-Bone Void Filler

United States
Fujifilm Kyowa Kirin Biologics Co., Ltd.

Completed

A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients (ARABESC)

Arthritis, Rheumatoid

United States, Bulgaria, Poland, Russian Federation, Germany, Romania, Ukraine, Canada, Chile, Czechia, Spain, Peru
Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Recruiting

Immunotherapy for Third Line Metastatic Colorectal Cancer (STIMVAX)

Metastatic Colorectal Cancer

United States
Biocon Biologics UK Ltd

Active, not recruiting

Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis (DEVOTE)

Postmenopausal Women With Osteoporosis

United Kingdom
Apeiron Biologics
Apeiron Respiratory Therapies GmbH

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled APN01 Developed as Treatment for COVID-19

Covid19

Austria
University Hospital, Ghent
Janssen Biologics B.V.

Completed

Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria (CRESPA)

Peripheral Spondylarthritis

Belgium
Biocon Biologics UK Ltd

Not yet recruiting

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Zhejiang Cancer Hospital
Innovent Biologics, Inc.

Recruiting

A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric Cancer

Unresectable Gastric Cancer

China
Baylor College of Medicine
Skye Biologics

Not yet recruiting

Efficacy of ActiveMatrix on Spinal SSI Rate

Surgical Site Infection | Spinal Stenosis Lumbar | Back Pain Lower Back Chronic
University of Pennsylvania
Theriva Biologics SL

Recruiting

huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer

Pancreatic Cancer | Serous Ovarian Cancer

United States
PT Kalbe Genexine Biologics
Genexine, Inc.

Recruiting

A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19

Covid19

Indonesia
Syneos Health
CuraTeQ Biologics Private Ltd.

Completed

Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair

Healthy Volunteers

New Zealand, Australia
Biocon Biologics UK Ltd

Active, not recruiting

Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis (STELLAR-2)

Moderate to Severe Chronic Plaque Psoriasis

United States
Innovent Biologics (Suzhou) Co. Ltd.
Fortrea

Completed

Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 ) (ORIENT-15)

Esophageal Squamous Cell Carcinoma

France, Spain, Belgium, Australia, United States, China, Hungary
Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Completed

Universal Anti-Viral Vaccine for Healthy Elderly Adults (ALLOPRIME)

Virus Diseases | Pneumonia | Influenza, Human | COVID-19 Respiratory Infection | ARDS, Human | RSV Pneumonia

United States
Adello Biologics, LLC
inVentiv Health Clinical

Completed

Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects (TPI-120)

Healthy Volunteers

United States
Trevena Inc.
Kestrel Biologic

Terminated

A Pilot Study of TRV130 for the Treatment of Fracture Pain

Pain

United States
Fudan University
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Taoyuan General Hospital
Medigen Vaccine Biologics Corp.

Recruiting

A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19

COVID-19 Vaccine

Taiwan
CanSino Biologics Inc.
Beijing Institute of Biotechnology

Terminated

A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents

COVID-19

Chile
Sun Yat-sen University
Innovent Biologics, Inc.

Active, not recruiting

HAIC Combined With PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC (HAICPD1-HCC)

Hepatocellular Carcinoma

China
Semmelweis University
Purgo Biologics Inc.; FORM-Lab

Completed

Evaluation of a Novel Horizontal Ridge Augmentation Technique in Dentistry

Bone Augmentation | Bone Loss, Alveolar

Hungary
Sichuan University
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients

Stage IV NSCLC

China
Eli Lilly and Company
AbCellera Biologics Inc.

Completed

A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

COVID-19

United States
Medtronic Spine LLC

Completed

Study Of Disc Anaesthesia For The Preoperative Diagnosis Of Chronic Lower Back Pain (SODA)

Low Back Pain

United States
Peking University
Innovent Biologics (Suzhou) Co. Ltd.

Unknown

Efficacy and Safety Evaluation of Sintilimab in Combination With IBI310 as Treatment in Patients With EBV-Positive Gastric Cancer

Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

China
Medtronic Spine LLC

Terminated

KAVIAR Study - Kyphoplasty And Vertebroplasty In the Augmentation and Restoration of Vertebral Body Compression Fractures

Vertebral Body Compression Fractures

United States, Canada
Medtronic Spine LLC

Terminated

Condition of Approval Study (COAST)

Lumbar Spinal Stenosis

United States
Medtronic Spinal and Biologics
Averion International Corporation

Terminated

Localized Alveolar Ridge Augmentation With Dental Implant (RidgeDI)

Alveolar Bone Loss

United States
Zhejiang Cancer Hospital
Akeso; Innovent Biologics, Inc.

Not yet recruiting

A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer

Vulvar and Vaginal Cancer

China
Sichuan University
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Advanced Squamous Cell Lung Cancer

Advanced Lung Squamous Cell Carcinoma

China
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)

Recruiting

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

Follicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | MALT Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Indolent Lymphoma | Refractory B-Cell Lymphoma

United States, Australia, China
Biocon Biologics UK Ltd
Biotrial

Completed

Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS (DENARIUS)

Healthy Volunteers

United States
Crescendo Biologics Ltd.
University Medical Center Groningen

Active, not recruiting

A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

Advanced and/or Metastatic Solid Tumours

Netherlands
Eli Lilly and Company
AbCellera Biologics Inc.

No longer available

Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19

COVID-19
Wake Forest University Health Sciences
Samaritan Biologics

Withdrawn

Evaluating Return to Continence and Potency Following Radical Prostatectomy

Prostate Cancer

United States
Y Biologics Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Korea, Republic of, Thailand, Australia
AGC Biologics S.p.A.
Horizon 2020 - European Commission

Terminated

Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma

Acute Myeloid Leukemia | Multiple Myeloma

Italy, Czechia
Eli Lilly and Company
AbCellera Biologics Inc.

Completed

A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) (BLAZE-5)

COVID-19

United States
Medtronic Spine LLC

Completed

Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®

Lumbar Spinal Stenosis

United States
Medtronic Spine LLC

Completed

CAFE Study - Cancer Patient Fracture Evaluation (CAFE)

Cancer | Spinal Fractures

United States, Canada, Australia, Sweden, Belgium, Germany, Hungary, United Kingdom
Medtronic Spine LLC

Withdrawn

Effects of X-STOP® Versus Laminectomy Study (EXELS)

Lumbar Spinal Stenosis
Medtronic Spine LLC

Completed

Medtronic SCORE Study - Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty (MDTSCORE)

Vertebral Body Compression Fractures (VCFs)

Germany, United States, Belgium
Medtronic Spinal and Biologics
Averion International Corporation

Terminated

Sinus Augmentation With Dental Implant (SinusDI)

Maxillary Sinus Bone Loss

United States
Medtronic Spinal and Biologics
Averion International Corporation

Terminated

Localized Alveolar Ridge Augmentation With Space Maintenance Devices (Ridge Mesh)

Alveolar Bone Loss

United States
Antengene (Hangzhou) Biologics Co., Ltd.

Recruiting

A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Advanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin Lymphoma

China
RenJi Hospital
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.

Unresectable Locally Advanced Pancreatic Cancer

China
CanSino Biologics Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

Poliomyelitis

Australia
CanSino Biologics Inc.
Beijing Institute of Biotechnology

Withdrawn

Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)

COVID-19
CanSino Biologics Inc.
Beijing Institute of Biotechnology

Completed

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

COVID-19

Mexico, Argentina, Chile, Pakistan, Russian Federation

Clinical Trials Sponsored by BioDlogics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations